Breaking News

ProBioGen Invests €20M to Expand Bio Production

Plans to double its workforce

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

ProBioGen AG, based in Berlin, Germany, is investing €20 million to expand operations and plans to double its workforce.   ProBioGen develops novel processes for the production of biopharmaceutical drug substances, with services ranges from cell line and process development to GMP contract manufacturing. The company also develops technologies to improve bioactive substances and has created a portfolio of proprietary rights for optimized biopharmaceutical manufacturing.   ProBioGen was recently g...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters